Enterprise Therapeutics Ltd
Quick facts
Phase 2 pipeline
Phase 1 pipeline
- ETD001 multiple once daily doses
- ETD001 multiple twice daily doses
- ETD001 single dose
- ETD002 - 14 day repeat dose
- ETD002 - 7 day repeat dose
- ETD002 - single dose
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: